A therosclerosis is a chronic inflammatory disease of large and midsized arteries incited by retention and subsequent oxidation of lipoproteins in the arterial wall and propagated by chronic inflammation. 1 Accumulating evidence indicates that this inflammation is controlled by both innate and adaptive immune responses against modified self-antigens in the vascular wall, such as oxidized low-density lipoprotein (LDL). [2] [3] [4] [5] However, it is also possible that loss of tolerance against normal self-antigens, such as apolipoprotein B100, may be involved. 6 Extracellular antigens are presented to CD4 + T-cells by dendritic cells and macrophages. CD4 + T-cells that recognize their specific antigen will develop into T-helper (Th) 1, Th2, Th17, or regulatory T-cells (Tregs), depending on the costimulatory molecules and cytokines expressed by antigen-presenting cells. In general terms, Th1 and Th17 cells are proinflammatory, Th2 cells provide B-cell help and Tregs control and suppress the activity of autoreactive Th cells. In accordance, it is now considered that the mode of CD4 + T-cell differentiation in response to plaque antigen-presentation plays a key role in determining plaque inflammation and disease progression. 3 There is consistent evidence from animal models that Th1 cells are proatherogenic. Th1 cells are characterized by expression of the potent proinflammatory cytokine interferon-γ (IFN-γ). Apoe -/-mice lacking either IFN-γ or IFN-γ receptors develop less atherosclerosis, [7] [8] [9] whereas injection of recombinant IFN-γ aggravates the disease. 10 Reduced atherosclerosis is also observed in LDL receptordeficient mice lacking T-bet, the transcription factor required for differentiation of naive T-cells into Th1 cells. 11 Analysis of cytokine expression in human atherosclerotic plaques suggests a predominance of Th1-promoting cytokines, 12 and T-cells isolated from plaques produce IFN-γ when challenged with oxidized LDL ex vivo. 13 The role of Th2 cells in atherosclerosis appears to be more multifaceted [14] [15] [16] than that of Th1 cells. Th2 cells are essential in inducing B-cell anti body isotype switching from IgM to IgG, and are typically charac terized by expression of interleukin (IL)-4, IL-5, and IL-13. Apoe 17,18 IL-5, in contrast, has been attributed a protective role because of its ability to stimulate the release of oxidized phospholipid-specific natural antibodies from B1-cells. These antibodies are believed to protect against atherosclerosis by inhibiting the macrophage uptake of oxidized LDL and by facilitating the clearance of apoptotic cells. 19, 20 Experimental studies have also attributed an atheroprotective role of certain oxidized LDL-specific IgG. 21, 22 The role of Th17 cells in atherosclerosis remains to be fully understood, 23 ) cells were analyzed by flow cytometry, and cytokine-release from activated mononuclear leukocytes was measured by multiplex technology. High numbers of Th2 cells were independently associated with decreased mean common carotid intima-media thickness. High numbers of Th2 cells were also independently associated with a reduced risk of acute myocardial infarction in women (hazard ratio, 0.19; 95% confidence interval, 0.06-0.56; P=0.002 for the highest versus the lowest tertile of Th2 cells). Moreover, release of the Th2 cytokine interleukin-4 from activated mononuclear leukocytes was independently associated with a reduced risk of CVD. No independent associations between Th1 cells and carotid intima-media thickness or CVD risk were found. Conclusion-Our observations provide the first clinical evidence for a protective role of Th2 immunity in CVD. They also suggest this protection is more prominent in women than in men. In spite of convincing evidence from experimentalbecause of inhibition of autoreactive T-cells and release of antiinflammatory cytokines, such as IL-10 and transforming growth factor-β. 24, 25 Although the role of Th1 and Th2 cells in atherosclerosis has been extensively studied in animal models of the disease, there are few studies addressing their potential clinical importance. It has been reported that Th1, but not Th2, cells are elevated in patients with acute coronary syndromes, 26, 27 but it remains to be clarified whether this reflects an acute response to myocardial damage or the underlying coronary disease. In the present study, we have determined the levels of Th1 and Th2 cells, identified as IFN-γ-and IL-4-expressing CD4 + cells, in mononuclear leukocytes from 700 subjects who participated in the Malmö Diet and Cancer Study, 28 and studied their association with baseline carotid intima-media thickness (IMT) and incidence of a first cardiovascular event during 15-years follow-up.
Materials and Methods

Study Population
The Malmö Diet and Cancer Study is a prospective cohort study examining the association between diet and cancer. Subjects born between 1926 and 1945, and living in Malmö were eligible for inclusion in the study. Between October 1991 and February 1994, every other participant was also invited to take part in a substudy focusing on cardiovascular risk (Malmö Diet and Cancer Study cardiovascular arm). In the present study, we randomly selected 700 participants, aged 63 to 68 years (mean age 65), from the cardiovascular arm of Malmö Diet and Cancer Study (n=6103). Participants underwent a medical history, physical examination, and laboratory assessment, as previously described in detail (Table 1) . 29 The study was approved by the Ethics Committee of the University of Lund and was conducted in accordance with the Helsinki Declaration. All subjects gave written consent.
Isolation of Mononuclear Leukocytes
Blood (15 mL) was collected in heparin tubes and layered on top of 15 mL lymphoprep before centrifugation at 1350g for 12 minutes at room temperature. The cell interface layer was carefully harvested, and the cells were then washed twice with 0.9% NaCl. The cells were resuspended in 1.7 mL autologous serum and 1.6 mL cold Roswell Park Memorial Institute (RPMI) 1640 medium with 20% dimethyl sulfoxide added. The cells were frozen slowly by placing them in a Styrofoam box at -80°C overnight. Frozen mononuclear cells were stored at -140°C.
Staining of Mononuclear Leukocytes and Flow Cytometry
The antibodies used in this study were PE/Cy7-anti-CD3, biotinPerCP-CD56, Pacific Blue-anti-CD4, PE-anti-IFN-γ, APC-anti-IL-4, biotinylated-anti-CD45/streptavidin coupled to CascadeYellow, and Alexa Fluor700-anti-CD8, all from Biolegend. Cell viability of CD45 + leukocytes was assessed with the viability dye 7-aminoactinomycin D (BioLegend). To enable measurement of Th1 and Th2 cells, mononuclear cells (4×10 5 cells/cell culture well) were incubated with phorbol 12-myristate 13-acetate (10 ng), ionomycin (0.2 µg), and brefeldin A (1 µg, all from Sigma) for 4 hours at 37°C. Stained cells were fixed in 1% paraformadehyde and measured on a CyAn ADP flow cytometer (Beckman Coulter). The analysis was performed with FlowJo 7.6 software (Tree Star). Absolute cell numbers in blood were calculated by multiplying percentages of gated lymphocyte populations with counts obtained from a blood cell count analysis, using a Sysmex K-1000 with data unit DA 1000 (TOA Medical Electronics Co).
Analysis of Cytokines in Cell Supernatants
Mononuclear cells (4×10 5 cells/cell culture well) were cultured in complete RPMI and stimulated with CD3/CD28 beads (1 bead per 2 cells; Miltenyi Biotec) for 72 hours at 37°C in a cell incubator (5% CO 2 ). Thereafter, the cell supernatants were stored at -80°C until analysis. The concentrations of released cytokine were determined with a multiplexed immunoassay (MesoScale Discovery).
B-Mode Ultrasound
Analysis of common and bulb carotid IMT was performed using an Acuson 128 CT system with a 7-MHz transducer, as described previously. 28, 30 Common carotid artery IMT area was calculated, as described by Wendelhag et al, 29 as the difference between the total area inside the adventitia and the lumen area.
Clinical End Points
We examined the first outcome cardiovascular events. The procedure for ascertaining outcome events has been detailed previously. 31, 32 Coronary events were defined as fatal or nonfatal myocardial infarction or death because of ischemic heart disease. Cardiovascular events were defined as coronary events or fatal or nonfatal stroke. Events were identified through linkage of the 10-digit personal identification number of each Swedish citizen with 3 registries: the 
Statistics
An independent sample t test was used to assess normally distributed continuous variables and a χ 2 test for proportions between cases and controls. Nonparametric test (Mann-Whitney) was used to assess nonnormally distributed continuous variables between cases and controls. Spearman correlation coefficients were used to examine the relationship among continuous variables as appropriate. Linear regression models were used to calculate independent associations. Kaplan-Meier curves were used to illustrate incidence of cardiovascular events in relation to T-cell tertiles, and differences was analyzed by log rank test. Cox proportional hazard regression was used to examine the association between T-cell tertiles and incident cardiovascular events. Plots of the hazard function in different groups over time did not indicate that the proportional-hazards assumption was violated.
Results
To determine viability, we analyzed the uptake of 7-aminoactinomycin D in thawed CD45 + cells by flow cytometry. The results demonstrated that 95% of the cells remained viable. Comparing cell numbers registered at freezing and thawing confirmed that no loss of cells had occurred. + T-cells or as cell counts per μL blood. CD56 was used to exclude a subset of T-cells called natural killer T-cells that also can produce substantial amounts of IFN-γ and IL-4. To determine whether Th1 and Th2 cell levels were associated with the functional characteristics of the peripheral blood mononuclear leukocytes (PBML) population, we activated peripheral blood mononuclear leukocytes (PBML) from each subject with CD3/CD28 beads for 72 hours at 37°C and analyzed the release of cytokines into the medium. There were significant associations between both the percentage and absolute number of Th1 cells and the release of proinflammatory cytokines, such as IFN-γ, IL-1β, IL-6, and tumor necrosis factor-α, but also with the release of IL-5 and IL-10 ( Table 2) . Also, Th2 cells demonstrated associations with the release of both proinflammatory and antiinflammatory cytokines (Table 2 ), but these were generally weaker than those observed for Th1 cells. Notably, there were no significant associations between the percentage or absolute number of Th2 cells and bead-induced release of IL-4 and IL-5.
Th1 and Th2 cells were significantly higher in women compared with men (93±72 versus 71±64 Th1 cells/µL and 5.4±4.7 versus 4.1±3.8 Th2 cells/µL, respectively; Table 3 except for IL-5 which was significantly higher in smokers and lower in subjects with BP-lowering medication and IL-10 which was lower in subject on antidiabetic medication (Table  3 ). Th1 and Th2 cells did not appear to be affected by lipid profile, as there were no correlations between Th1 and Th2 cells (percentage and absolute numbers) and cholesterol, LDL, highdensity lipoprotein (HDL), and triglycerides, except for a correlation between cholesterol and Th2 cell numbers (Spearman correlation coefficient=0.086; P=0.03), which was lost when adjusting for age and sex in a linear regression model. We next determined the association between Th1 and Th2 cells, respectively, and baseline carotid artery IMT and area. The percentage of CD4 + Th cells displayed significant inverse associations with common carotid mean IMT and area, but the associations were lost when taking age, sex, HDL, LDL, triglycerides, glucose, and systolic BP into account in a linear regression model (Table 4 ). Th2 cells (both percentage and absolute numbers) demonstrated significant inverse associations with the common carotid mean IMT and area, but not with the maximal IMT in the carotid bulb ( Table 4 ). The inverse associations between both the percentage and total number of Th2 cells, respectively, and common carotid IMT area remained after taking age, sex, HDL, LDL, triglycerides, glucose, and systolic BP into account in a linear regression model (P<0.05 for both). Controlling for the same risk factors, only Th2 cell counts were independently and inversely associated with mean IMT in the common carotid artery (P<0.05). No association was observed between Th1 cells and mean IMT or area in the common carotid artery. There were no significant associations between bead-activated release of IL-4, IL-5, IL-6, IL-10, IL-12p70, or IFN-γ and carotid IMT or area (data not shown).
During follow-up, 150 subjects had an incident CVD event, of which 84 had a coronary event and 66 had strokes. Subjects who suffered a hemorrhagic stroke were excluded when evaluating risk of CVD events, as these were considered to have a IFN-γ, pg/mL 35000±75000 34000±68000 35000±73000 33000±57000 34000±70000 55000±93000 38000±80000 34000±69000 36000±73000 31000±64000 34000±70000 44000±96000 36000±73000 30000±62000 Th1 cells, cells/µL nonatherosclerotic pathogenesis (11 of 66 strokes were hemorrhagic). There were significant trends of reduced risk of CVD events with increased number of Th1 and Th2 cells (Th1 log rank test P for trend=0.025; Th2 log rank test P for trend=0.019). There were also significant trends of reduced risk of coronary events with increased number of Th1 and Th2 cells (Th1 log rank test P for trend=0.005; Th2 log rank test P for trend=0.004), whereas no associations were found with the risk for ischemic stroke. Kaplan-Meier survival curves for Th2 cell tertiles and total CVD, coronary, and stroke events are shown in Figure 2 . The numbers of Th1 and Th2 cells were significantly higher in women compared with men (Table 3) . In a general linear model, including sex, incident CVD events, and the interaction between sex and incident CVD events, the interaction was significantly associated with the number of Th2 cells (P=0.023), but not with the number of Th1 cells, when adjusting for age, diabetes mellitus, hypertension, smoking, and LDL/HDL ratio. This indicates that the number of Th2 cells is associated with incident CVD events in a sex-specific way. Sex-stratified analyses of the association between the number of Th1 and Th2 cells, and incident coronary and stroke events revealed that women in the highest tertile of Th2 cells had a significantly reduced risk (5.3-fold) compared with women in the lowest tertile of Th2 cells (hazard ratio, 0.19; 95% confidence interval, 0.06-0.56; P=0.002), when adjusting for age, hypertension, diabetes mellitus, smoking, and LDL/HDL ratio (Table  5) . No significant association was found in men, or between the number of Th1 cells and incident coronary or stroke events.
Table 3. Associations Between Cytokines and T-Helper Cell Subsets and CVD Risk Factors
We next investigated the association between the release of Th1 and Th2 cytokines from CD3/CD28 bead-activated PBML and incident CVD. Only samples with detectable Th1-or Th2-related cytokine release were included in these analyses (n=440 for IL-4, n=373 for IL-5, n=612 for IL-10, n=307 for IL-12p70, and n=598 for IFN-γ). There were no significant differences in CVD events, sex, diabetes mellitus, antidiabetic medication, hypertension, BP-lowering medication, lipidlowering medication, smoking between subjects with cytokine values below and above the detection limit, indicating that subjects with detectable cytokine levels are representative of the whole population with a similar risk profile.
Using a Cox regression model, adjusting for sex, hypertension, diabetes mellitus, smoking, and the HDL/ LDL ratio, we tested whether release of the Th2 cytokine IL-4 was associated with a lower risk of developing IMT of the common carotid artery (CCA) and the carotid bulb, as well as the plaque area of the common carotid artery, was determined and correlated to Th1 and Th2 levels. The Spearman test was used to calculate r values. *P<0.05; and **P<0.01. 
Discussion
There is convincing evidence from animal models of atherosclerosis that adaptive immune responses play a critical role in the disease process. 3, 34 Mice lacking CD4 + T-cells develop less atherosclerosis, 15, 35, 36 whereas the disease is accelerated in severe combined immune-deficiency mice reconstituted with CD4 + T-cells. 37 Studies of the role of different CD4 + T-cell subsets have shown that Th1 cells are proatherogenic, Tregs atheroprotective, whereas the role of Th2 cells appears to be more complex with both proatherogenic and atheroprotective properties reported. 3 This has stimulated the development of novel therapies for prevention and treatment of CVD targeting the immune system. 38, 39 However, an important limitation in this development has been the poor understanding of the role of the immune system in the development of atherosclerosis and acute cardiovascular events in humans. The present report is the first prospective study of associations between Th1 and Th2 cells with the risk for acute myocardial infarction and stroke. It is also the first large study of associations between Th1 and Th2 cells with carotid IMT in a non-HIV population. The aim of these studies was primarily not to investigate whether Th1 and Th2 cells are useful biomarkers for predicting cardiovascular risk, but to investigate whether immune responses shown to be involved in the development of atherosclerosis in experimental animals are of importance in humans also.
Our findings demonstrate that high levels of Th2 cells are associated with less carotid IMT. However, it should be noted that the relatively small r-values for the correlations between Th subpopulations and IMT explains <1% of IMT. Increased release of the Th2 cytokine IL-4 from activated PBMLs was associated with lower risk for incidence of acute cardiovascular events, and remained significant when controlling for sex, hypertension, diabetes mellitus, smoking, and HDL/LDL ratio. Additionally, there was a significant association between high levels of Th2 cells and a lower risk for incident coronary events in women. It is important to keep in mind that association studies like this one do not provide information about causal relationships. However, in line with experimental studies, our findings suggest that Th2 are involved in the development of CVD in humans also. Moreover, as high levels of Th2 cells were associated with less carotid IMT and a lower risk for cardiovascular events, it appears reasonable to assume that these cells have an atheroprotective role in humans. The protective effect of Th2 cells in experimental studies has been associated with IL-5.
19,20 However, we did not observe any association between the presence of Th2 cells in the PBML preparations and the release of IL-5 from these cell preparations, when stimulated with anti-CD3/CD28 beads. In line with our data, IL-5 deficiency in mice did not change production of IL-4, IL-10, and IFN-γ, indicating that IL-5 may not rely primarily on altered Th1/Th2 balance as a mechanism to facilitate protection in atherosclerosis. 19 It should also be noted that the correlation between Th2 cells and release of Th2 cytokines shown in Table 2 is poor at best, indicating that cytokine release may not be a surrogate measure of the number of Th2 cells.
Interestingly, we found increased numbers of Th1 and Th2 cells in women. It is known that Th cell numbers differ between healthy men and women. 40, 41 It seems likely that the increased number of Th1 and Th2 cells found in our study Associations between tertiles of T helper 1 (Th1) of T helper 2 (Th2) cells and incident cardiovascular disease was calculated using Cox proportional hazard regression and adjusting for age, hypertension, diabetes mellitus, smoking, and LDL/ HDL. Significant associations between number of events and tertiles of cell numbers were determined with a χ 2 test for linear trend. *P<0.01; n.s., not significant.
reflects the generally increased numbers of Th cells in women.
It is possible that the sex difference in CVD risk associated with Th2 cells found in our study can be explained by or is at least related to the fact that women generally have increased numbers of Th cells. In apparent contrast with the experimental findings in mice, we were unable to demonstrate any associations between high levels of Th1 cells and carotid IMT or increased cardiovascular risk. This is clearly surprising in view of the marked association between the presence of Th1 cells and release of proinflammatory cytokines from activated PBML. However, high levels of Th1 cells were also associated with an increased release of the potentially atheroprotective cytokines IL-5 and IL-10, suggesting that other cells types may have counteracted any proatherogenic effect of Th1 cells. As discussed above, one should be careful to draw mechanistic conclusions based on clinical association studies, but the present study clearly does not provide support for a role of Th1 cells in CVD in humans. It should, however, be kept in mind that studying levels of Th1 cells in the circulation may not reflect their potential role inside the vascular wall and atherosclerotic lesions. Also, our data do not exclude the possibility that specific antigen-experienced effector memory Th1 cells, but not the entire Th1 population defined by their potential to release IFN-γ, are important for atherosclerosis development and clinical events.
It is also possible that to truly determine the role of Th1 cells in human atherosclerosis analysis of antigen-specificity need to be performed. For a CD4 + Th cell to acquire its effector function and produce cytokines in nonlymphoid tissues, antigen recognition is required. 42 Accordingly, an antigen-specific T-cell reactive against any plaque-derived protein, for example, apolipoprotein B100, 6 microbial proteins, or heat-shock proteins, 43 is likely to promote atherosclerosis, if it releases proinflammatory cytokines on encounter with its cognate antigen being presented by dendritic cells and macrophages present in the plaque. Because our study addressed whether the entire population of Th1 or Th2 cells, regardless of antigen specificity, could predict atherosclerosis, it is possible that antigenspecific approaches may yield other results. Of note, this study does not exclude a role for plaque-antigen-reactive Th1 cells, although we could only conclude that the entire pool of Th1 cells does not appear to correlate with carotid IMT or predict cardiovascular risk. Future studies are needed to elucidate the potential role of plaque-antigen-specific T-cell responses and their relationship with CVD. Definite conclusions on the role of antigen-specific T-cells in CVD might only be possible when defined antigens and specific T-cell populations can be studied with tetramer technology. It can also not be excluded that other phenotypic definitions of Th1 cells may have provided a different outcome.
There are, to our best knowledge, no previous studies investigating whether levels of Th1 and Th2 cells can predict cardiovascular events. There are, however, several studies analyzing Th cell subsets in patients with various coronary syndromes. Methe et al observed elevations of Th1 levels in patients with acute coronary syndrome compared with patients with stable angina or unheralded myocardial infarction. 26 Similarly, others have reported that Th1, but not Th2, cells are increased in patients with acute myocardial infarction and unstable angina compared with patients with stable angina. 27, 44 Cardiovascular complications are more common in HIV-infected individuals than in uninfected individuals and that antiretroviral therapy, which increases T-cell counts, reduces the cardiovascular risk. 45 We do, however, observe clear differences in risk associated with Th1 and Th2 cells comparing men and women, indicating that increased atherosclerosis cannot be explained by reduced levels of Th cells, independently of Th1 or Th2 subtype.
T 
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-DR + did show a significant correlation to carotid IMT, but the significance was lost when adjusting for risk factors. 47 Our study is the first to show an inverse association between a T-cell subset (Th2 cells) and carotid IMT, even after adjustment for traditional risk factors.
There are some limitations of the present study that need to be considered. Most importantly, our analyses were performed on cells that had been stored at -140°C for several years. As compared with initiating new prospective studies, this has the obvious advantage of allowing studies to be completed within a relatively short period of time. However, it remains to be fully established how well-thawed cells are representative of the original cell population. Although we were unable to detect any loss of cells when comparing cell numbers at freezing and thawing, we cannot exclude the possibility of a selective loss of Th1 and Th2 cells, as these represent only a small fraction of all mononuclear cells.
In conclusion, our observations provide the first clinical evidence for a role of Th2 cells in CVD and are in line with experimental studies, suggesting that shifting adaptive immune responses toward Th2 is protective. However, in contrast with experimental animal data, we found no association between Th1 cells and CVD.
